About me

Head of Data Management, conceptualizing and carrying out all clinical data management activities for 14 planned European countries participating in an international multi-center, multi-randomized phase III open label prospective study for acute lymphoblastic leukemia, ALLTogether. Experienced with quantitative applied research and statistics and the development of usable research tools in several therapeutic areas, including clinical trials and individual-centered research in rheumatology, immunology, and oncology. Postdoctoral research focused on complex interactions among quantified subjective factors and their prognostic capability: linking the first experience of patient symptoms and sensations through an online, interactive questionnaire together with planned analyses of biological data to potentially aid in diagnosing lung cancer earlier and add to the understanding of symptoms and bodily perception through bio-behavioral research. Doctoral research centralized on optimizing precision medicine in rheumatoid arthritis through randomized trials – focusing on prediction and outcomes of traditional and novel pharmaceutical therapies through individualized patient profiles with biomarkers and risk factors, and assessing integrative manual therapy in treating chronic pain.

Research description

h-index: 6; citations: >500; publications: 11


- Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate model. Levitsky A, Pernemalm M, Bernhardson B, Forshed J, Kölbeck K, Olin M, Henriksson R, Lehtiö J, Tishelman C, Eriksson LE. Sci Rep. 2019 Nov 11;9(1):16504. doi:10.1038/s41598-019-52915-x.

- Joint Mobilization of the Hands of Patients With Rheumatoid Arthritis: Results From an Assessor-Blinded, Randomized Crossover Trial. Levitsky A, Kisten Y, Lind S, Nordström P, Hultholm H, Lyander J, Hammelin V, Gentline C, Giannakou I, Faustini F, Skillgate E, van Vollenhoven R, Sundberg T.  J Manipulative Physiol Ther. 2019 Mar 14. pii: S0161-4754(18)30012-5.

- Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial. Levitsky A, Brismar K, Hafström I, Hambardzumyan K, Lourdudoss C, van Vollenhoven RF, Saevarsdottir S. RMD Open. 2017 Aug 9;3(2):e000458.

- Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials. Levitsky A, Wick MC, Möttönen T, Leirisalo-Repo M, Laasonen L, Korpela M, van Vollenhoven RF, Rantalaiho V. Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1065-1071.

- Clinical roundup: selected treatment options for rheumatoid arthritis. Kaltenborn manual mobilization. Levitsky A, Kisten Y, Sundberg T, van Vollenhoven R. Altern. Complement. Ther. 2016 Aug;22(4):175.

- Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial. Levitsky A, Erlandsson MC, van Vollenhoven RF, Bokarewa MI. BMC Med. 2015 Sep 30;13:247.

- Detection of clinically manifest and silent synovitis in the hands and wrists by fluorescence optical imaging. Kisten Y, Györi N, Af Klint E, Rezaei H, Levitsky A, Karlsson A, van Vollenhoven R. RMD Open. 2015 Jun 19;1(1):e000106.

- Predicted vs. observed radiographic progression in early rheumatoid arthritis (POPeRA): results from a randomized trial. Levitsky A, Forslind K, van Vollenhoven RF. Scand J Rheumatol. 2015;44(5):348-53.

- Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. van Vollenhoven RF, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrøm K, Aringer M, Bootsma H, Boumpas D, Bruce IN, Cervera R, Clarke A, Costedoat-Chalumeau N, Czirják L, Derksen R, Dörner T, Gordon C, Graninger W, Houssiau F, Inanc M, Jacobsen S, Jayne D, Jedryka-Goral A, Levitsky A, Levy R, Mariette X, Morand E, Navarra S, Neumann I, Rahman A, Rovensky J, Smolen J, Vasconcelos C, Voskuyl A, Voss A, Zakharova H, Zoma A, Schneider M. Ann Rheum Dis. 2014 Jun;73(6):958-67.

- Biologics in SLE: towards new approaches. van Vollenhoven RF, Parodis I, Levitsky A. Best Pract Res Clin Rheumatol. 2013 Jun;27(3):341-9.

- Rituximab in the management of systemic lupus erythematosus. Levitsky A, Linder S, van Vollenhoven R. Rheumatology Science and Practice 2013 Apr; 51(3):223–239.


Ph.D. Medical Science, Karolinska Institutet

M.Sc. Global Health, Karolinska Institutet

B.Sc. Human Factors Psychology; MR. Aerospace Life Sciences,

Embry-Riddle Aeronautical University

Academic honours, awards and prizes

ISOQOL conference, Top four submissions:

Plenary Session Presenter: Cutting Edge Research, ISOQOL, 2018; Dublin, Ireland: Analysis of early predictive lung cancer symptoms and sensations by orthogonal projections to latent structures (OPLS)

Loading bibliometrics...